Rogue Company : Revealing the Issues
New reports have focused a intense light on Bull Pharma, igniting serious questions regarding its operational strategies. Allegations of dubious marketing approaches, potential clinical risks linked with its products, and assertions of intentional deceptive reporting have fueled a increasing back